Integrated Diagnostics Holdings plc (FRA:8I8)
Germany · Delayed Price · Currency is EUR 0.5400
0.00 (0.00%)
At close: Jan 16, 2026
FRA:8I8 Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 7,395 | 5,720 | 4,123 | 3,605 | 5,225 | 2,656 | |
Revenue Growth (YoY) | 42.88% | 38.74% | 14.35% | -31.00% | 96.69% | 19.30% |
Cost of Revenue | 4,277 | 3,538 | 2,598 | 2,143 | 2,421 | 1,314 |
Gross Profit | 3,118 | 2,182 | 1,524 | 1,462 | 2,804 | 1,343 |
Selling, General & Admin | 1,169 | 963.56 | 722.02 | 589.43 | 533.18 | 329.09 |
Other Operating Expenses | -50.36 | -47.36 | -3.92 | -13.76 | -15.75 | -14.09 |
Operating Expenses | 1,177 | 964.51 | 769.35 | 605.58 | 542.08 | 357.13 |
Operating Income | 1,941 | 1,217 | 755 | 856.48 | 2,262 | 985.45 |
Interest Expense | -186.57 | -170.57 | -141.69 | -122.68 | -98 | -67.85 |
Interest & Investment Income | 144.68 | 144.68 | 72.78 | 95.37 | 113.18 | 53.12 |
Currency Exchange Gain (Loss) | 303.47 | 303.47 | 87.8 | 188.44 | -17.91 | -12.58 |
Other Non Operating Income (Expenses) | -494.32 | -26.32 | -19.3 | -12.91 | -20.03 | -3.68 |
EBT Excluding Unusual Items | 1,708 | 1,468 | 754.59 | 1,005 | 2,239 | 954.46 |
Merger & Restructuring Charges | - | - | - | -22.26 | - | - |
Impairment of Goodwill | - | - | -11.27 | - | - | - |
Gain (Loss) on Sale of Investments | -26 | -26 | - | -142.95 | - | - |
Gain (Loss) on Sale of Assets | -2.69 | -2.69 | 0.73 | -0.2 | 0.08 | 0.1 |
Asset Writedown | - | - | -6.71 | -1.83 | - | - |
Other Unusual Items | - | - | - | 16.18 | -6.98 | 14.52 |
Pretax Income | 1,680 | 1,440 | 737.36 | 853.65 | 2,232 | 969.08 |
Income Tax Expense | 431.22 | 431.22 | 268.99 | 327.06 | 739.82 | 359.6 |
Earnings From Continuing Operations | 1,248 | 1,008 | 468.36 | 526.58 | 1,493 | 609.48 |
Minority Interest in Earnings | 69.06 | 69.06 | 41.94 | 14.53 | -79.9 | -15.47 |
Net Income | 1,317 | 1,077 | 510.3 | 541.11 | 1,413 | 594.02 |
Net Income to Common | 1,317 | 1,077 | 510.3 | 541.11 | 1,413 | 594.02 |
Net Income Growth | 55.48% | 111.14% | -5.69% | -61.69% | 137.81% | 16.26% |
Shares Outstanding (Basic) | 581 | 594 | 600 | 600 | 600 | 600 |
Shares Outstanding (Diluted) | 581 | 594 | 600 | 600 | 600 | 600 |
Shares Change (YoY) | - | -1.06% | - | - | - | - |
EPS (Basic) | 2.27 | 1.82 | 0.85 | 0.90 | 2.35 | 0.99 |
EPS (Diluted) | 2.27 | 1.82 | 0.85 | 0.90 | 2.35 | 0.99 |
EPS Growth | 55.48% | 113.40% | -5.69% | -61.69% | 137.81% | 16.26% |
Free Cash Flow | - | 1,359 | 220.22 | -91.03 | 2,016 | 764.14 |
Free Cash Flow Per Share | - | 2.29 | 0.37 | -0.15 | 3.36 | 1.27 |
Dividend Per Share | - | 0.864 | - | - | 2.170 | 0.763 |
Dividend Growth | - | - | - | - | 184.23% | 0.14% |
Gross Margin | 42.16% | 38.14% | 36.98% | 40.56% | 53.67% | 50.54% |
Operating Margin | 26.25% | 21.28% | 18.31% | 23.76% | 43.29% | 37.10% |
Profit Margin | 17.82% | 18.84% | 12.38% | 15.01% | 27.04% | 22.36% |
Free Cash Flow Margin | - | 23.77% | 5.34% | -2.53% | 38.59% | 28.77% |
EBITDA | 2,224 | 1,517 | 1,014 | 1,063 | 2,414 | 1,104 |
EBITDA Margin | 30.07% | 26.52% | 24.61% | 29.50% | 46.20% | 41.57% |
D&A For EBITDA | 282.56 | 300.05 | 259.46 | 206.99 | 151.83 | 118.63 |
EBIT | 1,941 | 1,217 | 755 | 856.48 | 2,262 | 985.45 |
EBIT Margin | 26.25% | 21.28% | 18.31% | 23.76% | 43.29% | 37.10% |
Effective Tax Rate | 25.67% | 29.95% | 36.48% | 38.31% | 33.14% | 37.11% |
Advertising Expenses | - | 150.76 | 98.03 | 123.44 | 96.75 | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.